P

    Privia Health Group Inc (PRVA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $20.49
    -0.30 (-1.44%)

    Market Cap: $2.62B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(18/23)
    Avg Surprise
    +35.14%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.24
    Range$0.18 - $0.32
    10 analysts
    EPS Revisions
    3
    0
    7d
    4
    4
    30d
    EPS Estimate Drift
    90d ago$0.26+8.5%
    60d ago$0.26+7.9%
    30d ago$0.26+6.8%
    7d ago$0.26+7.2%
    Current$0.24
    Revenue Consensus
    $610M
    Range$585M - $650M
    14 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.14
    Range$0.03 - $0.50
    11 analysts
    Revenue Consensus
    $685M
    Range$645M - $732M
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.14---
    Sep 26EST
    		-$0.24---
    Jun 26
    Reported Aug 6
    		$0.07$0.08-12.50%Miss+250.0%
    Mar 26
    Reported May 7
    		$0.19$0.25-24.00%Miss-13.6%
    Dec 25
    Reported Feb 26
    		$0.07$0.04+75.00%Beat-66.7%
    Sep 25
    Reported Nov 6
    		$0.29$0.22+31.82%Beat+45.0%
    Jun 25
    Reported Aug 7
    		$0.02N/A-60.00%Miss-89.5%
    Mar 25
    Reported May 8
    		$0.22$0.18+22.22%Beat+22.2%
    Dec 24
    Reported Feb 27
    		$0.21$0.20+4.58%Beat+950.0%
    Sep 24
    Reported Nov 7
    		$0.20$0.20+0.00%Beat+17.6%
    Jun 24
    Reported Aug 8
    		$0.19$0.18+5.56%Beat+11.8%
    Mar 24
    Reported May 9
    		$0.18$0.15+20.00%Beat+12.5%
    Dec 23
    Reported Feb 27
    		$0.02$0.04-50.00%Miss-85.7%
    Sep 23
    Reported Nov 3
    		$0.17$0.16+6.25%Beat+30.8%
    Jun 23
    Reported Aug 3
    		$0.17$0.14+21.43%Beat+30.8%
    Mar 23
    Reported May 4
    		$0.16$0.14+14.29%Beat+33.3%
    Dec 22
    Reported Feb 28
    		$0.14$-0.03+566.67%Beat+227.3%
    Sep 22
    Reported Nov 10
    		$0.13$0.12+8.33%Beat+230.0%
    Jun 22
    Reported Aug 11
    		$0.13$0.10+30.00%Beat+107.7%
    Mar 22
    Reported May 12
    		$0.12$0.09+33.33%Beat+100.0%
    Dec 21
    Reported Mar 22
    		$-0.11$-0.13+15.38%Beat-210.0%
    Sep 21
    Reported Nov 8
    		$-0.10$-0.15+33.33%Beat-
    Jun 21
    Reported Aug 9
    		$-1.68$-1.55-8.39%Miss-
    Mar 21
    Reported Apr 30
    		$0.06$0.04+50.00%Beat-
    Dec 20
    Reported Mar 3
    		$0.10$0.08+25.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio33.05EV/EBITDA39.69x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin1.19%Operating Margin1.86%
    ROE4.31%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.62xQuick Ratio1.62x
    Trading Statistics
    Beta0.90Avg Volume1.21M
    52-Week High$28.8252-Week Low$19.53

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$21.08
    SMA 20$21.71
    SMA 50$24.20
    SMA 200$23.30
    EMA 10$21.12
    EMA 20$21.83
    EMA 50$23.00
    EMA 200$23.36

    MACD

    Line: -0.95Signal: -0.96Hist: 0.00

    ADX

    ADX: 32.8+DI: 14.3-DI: 33.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down32.0
    PSAR$22.80

    Bollinger Bands

    Upper Band$23.52
    Lower Band$19.89
    %B Position1669%(Upper)
    Band Width0.16

    RSI (14-Day)

    Oversold
    25.2

    Momentum Oscillators

    Stoch %K4.8
    Stoch %D10.7
    Williams %R-92.4
    ROC (10d)-4.7%
    Momentum-1.01
    CCI (20d)-127.6
    MFI (14d)26.2

    Volatility Measures

    ATR (14d)$0.69(3.4%)
    StdDev (20d)0.91
    Hist Vol33.0%(Moderate)

    Volume Flow

    VWAP$20.53
    OBV-18.0M
    AD Line-2.2M
    CMF (20d)0.014

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.7x
    VWMA (20d)$21.85

    Pivot Points

    R3$21.67
    R2$21.46
    R1$21.13
    Pivot Point$20.91
    S1$20.58
    S2$20.37
    S3$20.04

    Advanced Oscillators

    TSI-42.47
    Ultimate Osc30.5
    KST-155.35

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$632.63M$603.85M$541.17M$580.42M$521.15M$480.10M$460.90M$437.92M$422.33M$415.24M$440.83M$417.28M
    Cost of Revenue$69.36M$68.42M$66.85M$61.44M$64.92M$59.53M$59.77M$56.07M$57.11M$54.06M$52.41M$50.32M
    Gross Profit$563.27M$535.43M$474.32M$518.98M$456.24M$420.57M$401.13M$381.85M$365.22M$361.19M$388.42M$366.96M
    Operating Expenses$551.50M$528.00M$463.05M$504.58M$452.90M$415.35M$395.88M$376.04M$360.12M$360.36M$387.00M$361.42M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$39.66M$41.47M$29.27M$39.64M$37.52M$31.72M$34.42M$30.70M$28.92M$32.12M$29.60M$27.23M
    Operating Income$11.77M$7.42M$11.28M$14.40M$3.34M$5.22M$5.25M$5.81M$5.10M$823,000$1.42M$5.54M
    Interest Income$1.67M$0$0$0$2.41M$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$16.75M$9.31M$13.37M$16.67M$5.74M$8.15M$8.02M$7.98M$8.06M$3.81M$4.27M$8.43M
    Income Tax Expense$7.02M$5.60M$2.79M$6.87M$2.46M$2.10M$2.65M$4.00M$3.42M$751,000$1.94M$2.49M
    Net Income$9.73M$3.71M$10.59M$9.81M$3.29M$6.05M$5.37M$3.98M$4.64M$3.06M$2.32M$5.94M
    EBITDA$18.44M$12.59M$16.03M$19.44M$5.92M$10.05M$9.85M$9.77M$9.88M$5.63M$3.19M$10.16M
    EBIT$15.08M$9.31M$13.37M$16.67M$3.34M$8.15M$8.02M$7.98M$8.06M$3.81M$1.42M$8.43M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRVA

    News

    Price to sales forward of Privia Health Group, Inc. – NASDAQ:PRVA

    The article displays the "Price to sales forward" metric for Privia Health Group, Inc. (NASDAQ: PRVA) on a TradingView page. It shows a table with "Period," "Value," "Change," and "Change %" but the specific financial data is not populated. The content primarily consists of navigation links and general information about TradingView.

    TradingView•8/26/26•
    Neutral

    Should Stronger 2026 Guidance and New Board Expertise Require Action From Privia Health Group (PRVA) Investors?

    Privia Health Group (PRVA) recently reported strong Q2 2026 results, raising its full-year revenue outlook and appointing an experienced healthcare executive, Dr. Opella Ernest, to its Board. This positive guidance and new expertise could significantly influence the company's long-term investment narrative, especially in scaling its value-based care model. Investors should consider these developments while also weighing potential risks like rising healthcare labor and technology costs.

    Simply Wall Street•8/19/26•
    Somewhat-Bullish

    Should Stronger 2026 Guidance and New Board Expertise Require Action From Privia Health Group (PRVA) Investors?

    Privia Health Group (PRVA) recently reported strong Q2 2026 results with increased sales and profitability, raising its full-year 2026 GAAP revenue outlook to the high end of its prior range. The company also appointed Dr. Opella Ernest to its Board, bringing valuable healthcare expertise. Investors should consider how this stronger guidance and new board addition impact Privia's investment narrative, particularly concerning its ability to manage rising costs and scale its value-based care model.

    Simply Wall Street•8/19/26•
    Bullish

    Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

    Privia Health Group, Inc. has announced the appointment of Dr. Opella Ernest to its Board of Directors, effective September 1, 2026. Dr. Ernest, who also joins the Compliance Committee, brings over 20 years of healthcare executive experience, including significant expertise in value-based care and clinical operations. This appointment is expected to bolster Privia Health's growth and network expansion across the U.S.

    Yahoo! Finance Canada•8/19/26•
    Bullish

    Privia Health adds Dr. Opella Ernest to board of directors

    Privia Health Group Inc. (NASDAQ:PRVA) has announced the appointment of Dr. Opella Ernest to its board of directors, effective September 1, 2026. Dr. Ernest, who currently serves as President of HCSC Markets at Health Care Service Corporation, will also join the board’s Compliance Committee. Her extensive background in healthcare leadership and clinical practice is expected to bolster Privia Health's strategic direction.

    Investing.com•8/18/26•
    Somewhat-Bullish

    Frequently Asked Questions About PRVA

    Does PRVA pay dividends?
    Privia Health Group Inc (PRVA) does not currently pay a regular dividend.
    What is PRVA's P/E ratio?
    Privia Health Group Inc has a price-to-earnings (P/E) ratio of 33.05.
    What is PRVA's market cap?
    Privia Health Group Inc (PRVA) has a market capitalization of $2.62B with a current stock price of $20.49.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In